pembrolizumab,ALKS 4230
Merck,Alkermes
['ovarian', 'melanoma', 'alkermes']
we are proud to have participated in #asco23. as our studies in #ovariancancer and mucosal #melanoma continue, we look forward to sharing future updates from the artistry clinical trial program. 
Developing innovative medicines to help address pressing public health challenges – #mentalillness, #addiction & #cancer. Guidelines: https://t.co/oR0kiGaWkK